A trispecific antibody targeting EGFR/cMET/VEGF-A demonstrates multiple mechanisms of action to inhibit wild-type and mutant NSCLC animal models.
针对 EGFR/cMET/VEGF-A 的三特异性抗体表现出多种作用机制，可抑制野生型和突变型 NSCLC 动物模型
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1533059
Jin Ying, Sun Ping, Chen Peng, Xu Yuqiang, Mu Guangmao, Zha Zhengxia, Wu Simin, Fu Meixia, Jiang Hao, Huang Sheng, Zhou Fulai, Han Chao, Chiu Mark L
